The active ingredient in Ozempic is semaglutide, a lab-made version of a hormone your body already produces called GLP-1. Semaglutide drives weight loss through several overlapping mechanisms: it reduces hunger signals in the brain, slows down digestion so you feel full longer, and improves how your body handles insulin and blood sugar. In clinical trials, people taking semaglutide lost between 9.6% and 17.4% of their body weight, depending on the study and dosage.
How Semaglutide Mimics a Natural Hormone
Your gut naturally releases a hormone called GLP-1 (glucagon-like peptide-1) after you eat. It tells your brain you’re satisfied, signals your pancreas to release insulin, and slows the movement of food through your stomach. The problem is that natural GLP-1 breaks down in minutes. Semaglutide is engineered to resist that breakdown, so a single weekly injection keeps GLP-1 receptors activated for days.
Each 1 mL of Ozempic solution contains 1.34 mg of semaglutide along with a handful of inactive ingredients: a phosphate buffer to keep the pH stable, propylene glycol, phenol as a preservative, and water. None of these inactive components play a role in weight loss. Semaglutide is doing all the heavy lifting.
What Happens in Your Brain
Semaglutide crosses into the brain and acts on areas that control appetite. It activates GLP-1 receptors in the hypothalamus, the region that regulates hunger and satiety, effectively turning down the volume on hunger signals. People on semaglutide consistently report feeling less interested in food and thinking about it less often throughout the day.
The drug also appears to change how your brain’s reward system responds to food. Research has shown that semaglutide reduces motivation for palatable, high-calorie food. Interestingly, it doesn’t seem to dampen the pleasure of eating itself. Instead, it reduces the anticipatory craving triggered by food cues, like the sight or smell of something tempting. In animal studies, semaglutide actually increased dopamine activity during the moment of eating but had no effect on dopamine during the presentation of food cues. The result is that you’re less driven to seek out food, but you can still enjoy a meal when you have one.
How It Slows Your Digestion
One of semaglutide’s most powerful effects is dramatically slowing gastric emptying, the rate at which food leaves your stomach. In a study of women with obesity, semaglutide increased the amount of food still sitting in the stomach four hours after a meal to 37%, compared to 0% retention in the placebo group. The time it took for half a meal to leave the stomach jumped from about 118 minutes with placebo to 171 minutes with semaglutide.
This happens because semaglutide inhibits the muscular contractions that push food from your stomach into your small intestine while simultaneously increasing tension in the pylorus, the valve between the two. The net effect is that food stays in your stomach longer, which sends sustained “I’m full” signals to your brain. It’s also why smaller portions feel more satisfying on the medication.
This same mechanism is directly responsible for the most common side effects. Nausea, vomiting, and abdominal discomfort occur because the stomach is holding onto food longer than it normally would. About 19% of patients on GLP-1 medications develop clinically delayed gastric emptying. These side effects tend to be worst during the early weeks and when the dose is increased, which is why doctors start patients on a low dose and gradually raise it.
Effects on Blood Sugar and Insulin
Semaglutide was originally developed for type 2 diabetes, and its effects on blood sugar play a supporting role in weight loss. When GLP-1 receptors are activated, the pancreas releases more insulin in response to rising blood sugar, but only when blood sugar is actually elevated. This glucose-dependent mechanism means the drug doesn’t cause dangerous drops in blood sugar on its own.
At the same time, semaglutide suppresses glucagon, a hormone that tells the liver to release stored sugar into the bloodstream. With less glucagon circulating, the liver produces less unnecessary glucose. The combination of better insulin response and lower glucagon output keeps blood sugar more stable, which reduces the sharp spikes and crashes that can trigger hunger and cravings. Semaglutide also appears to improve insulin sensitivity in peripheral tissues, meaning your muscles and organs become better at absorbing glucose from the blood.
How Much Weight People Actually Lose
The STEP clinical trial program tested semaglutide at 2.4 mg per week (the dose used in Wegovy, the weight-loss branded version) across thousands of participants. In people without type 2 diabetes, average weight loss ranged from 14.9% to 17.4% of body weight over 68 weeks. For someone starting at 220 pounds, that’s roughly 33 to 38 pounds. In a longer 104-week trial, participants lost an average of 15.2% of their body weight, compared to just 2.6% in the placebo group.
People with type 2 diabetes lost somewhat less, averaging 9.6% body weight loss over 68 weeks. This is a consistent finding across GLP-1 medications: the presence of diabetes seems to reduce the total amount of weight lost, though the loss is still clinically significant.
Ozempic vs. Wegovy: Same Ingredient, Different Purpose
Ozempic and Wegovy contain the exact same active ingredient. The difference is regulatory. Ozempic is FDA-approved for managing type 2 diabetes and reducing cardiovascular and kidney risks in people with diabetes. Its maximum dose is 2 mg per week. Wegovy is approved specifically for weight management in adults and children 12 and older, and its maximum dose goes up to 2.4 mg per week as an injection.
Both medications start at a low dose of 0.25 mg per week for the first four weeks, then increase to 0.5 mg. From there, the dose can be raised further depending on the indication and how well you tolerate it. This gradual approach gives your digestive system time to adjust and reduces the severity of nausea and other gut-related side effects.
Why It Works on Multiple Fronts
What makes semaglutide unusually effective for weight loss is that it doesn’t rely on a single mechanism. It simultaneously reduces how much you want to eat, makes you feel full faster and longer, stabilizes the blood sugar swings that drive cravings, and changes how your brain’s reward pathways respond to food. Most older weight-loss medications targeted only one of these pathways. Semaglutide hits several at once, which is a large part of why clinical trial results have been so much stronger than what previous medications achieved.